Department of Genomic Health, Geisinger, Danville, PA, USA (Drs Jones, Gidding); Heart and Vascular Institute, Geisinger, Danville, PA, USA (Dr Jones).
Department of Genomic Health, Geisinger, Danville, PA, USA (Drs Jones, Gidding).
J Clin Lipidol. 2024 Jul-Aug;18(4):e525-e536. doi: 10.1016/j.jacl.2024.03.010. Epub 2024 Apr 1.
The International Atherosclerosis Society (IAS) published an evidence-informed guidance for familial hypercholesterolemia (FH) that provides both clinical and implementation recommendations. We reference examples of strategies from the literature to explore how these implementation recommendations can be tailored into implementation strategies at the local-level for stakeholders guided by a framework proposed by Sarkies and Jones.
Four authors of the IAS guidance selected two published exemplar implementation recommendations for detection, management, and general implementation. Each recommendation was described as an implementation strategy using Proctor's guidance for specifying and reporting implementation strategies. It recommends reporting the actor (who), action (what), action-target (who is impacted), temporality (how often), and dose (how much) for each implementation strategy.
Detection: A centralized cascade testing model, mobilized nurses (actor) to relative's homes, after the diagnosis of the proband (temporality), once (dose) to consent, obtain a blood sample and health information (action) on relatives (action-target).
A primary care initiative to improve FH management included an educational session (action) with clinicians (action-target), computer-based reminder message and message to patients to have their cholesterol screened once (dose) at a visit or outreach (temporality) by researchers (actor). General: A partnership between a statewide public pathology provider, local public hospital network, primary health network, government health ministry, and an academic university (actors) was established to implement a primary-tertiary shared care model (action) to improve the detection of FH (action-target).
We demonstrate that implementation recommendations can be specified and reported for different local contexts with examples on monitoring, evaluation, and sustainability in practice.
国际动脉粥样硬化学会(IAS)发布了一份有关家族性高胆固醇血症(FH)的循证指导,提供了临床和实施建议。我们参考文献中的策略示例,探讨如何根据 Sarkies 和 Jones 提出的框架,为利益相关者制定将这些实施建议纳入地方层面实施策略的方法。
IAS 指导的四位作者选择了两个已发表的 FH 检测、管理和一般实施的实施范例建议。使用 Proctor 规范和报告实施策略的指南,将每个建议描述为一项实施策略。它建议报告实施策略的执行者(谁)、行动(什么)、行动目标(谁受到影响)、频次(多久一次)和剂量(多少)。
检测:一种集中的级联测试模型,在先证者诊断后(时间性),动员护士(执行者)前往亲属家中,一次性(剂量)获得同意、采集血样和健康信息(行动)。
改善 FH 管理的初级保健倡议包括对临床医生(行动目标)进行教育课程(行动),同时向患者发送计算机提醒信息和就诊或外展时筛查胆固醇的信息(行动)。
州立公共病理提供者、当地公共医院网络、初级保健网络、政府卫生部和学术大学之间建立了合作伙伴关系(执行者),以实施一种主要-次要共享护理模式(行动),改善 FH 的检测(行动目标)。
我们通过监测、评估和实践可持续性的示例,展示了如何针对不同的地方背景,具体说明和报告实施建议。